[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fWy79AM79jNmiKOh0K3CF4zkG3eBI6lS5185nDxt5TK4":8,"$fd-oP2wll-8jXBXUa0CQU0vLqhq2QBYl7gZD3_D5bhUY":54,"$fh1-cNhU_AvbSeMFbBk3giAxQtr8dqPZ_Ozya6cAzwQk":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":25,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":22,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},45903,870152,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//2Y8Bbxws0VtuCfj0fpMzGBhQb12bQxmb.png","陆海琦","浙江大学医学院附属邵逸夫医院","肿瘤科","副主任医师",5,0,"肝癌IV期腺癌常用口服靶向药物：安全用药全指南","","https://ystcdn.venuertc.com/venue/AI/f0f3c1d6-21be-4346-88d9-c01153c9db07.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肝癌IV期腺癌常用口服靶向药物：安全用药全指南\u003C/h2>\n\n  \u003Cdiv class=\"material-section material-bg-1\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">一、口服靶向药物，您真的了解吗？🌱\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        说起“靶向药”，也许不少患者家属都有所耳闻。它作为近年来用于多种重大疾病全身治疗的明星药品，能通过精准阻断特定分子通路，帮助患者长期管理病情。今天的内容，围绕肝癌IV期腺癌全身治疗中广泛应用的口服靶向药物，解析7个关键实用细节——剂型、用法、禁忌、不良反应、相互作用、特殊人群与储存方法。看完后，希望每一位使用口服靶向药的家庭都能做到安心用药，减少风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-2\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">二、主要成分和剂型特点\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        多数口服靶向药物以\u003Cstrong>小分子多靶点酪氨酸激酶抑制剂\u003C/strong>为主，常见有效成分包括索拉非尼、仑伐替尼等，通常制成薄膜包衣片或胶囊剂型。规格差异明显，以片剂最常用，规格一般在\u003Cstrong>2.5mg~200mg/片\u003C/strong>不等。\u003Cbr>\n        \u003Cspan class=\"material-key-tip\">剂型小知识：\u003C/span>大部分此类药品不可掰开、咀嚼或捣碎，确保药物释放速率稳定，避免局部刺激。服用时应整片（或整粒）吞服，配适量温水。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">💡\u003C/span>\n        \u003Cb>实用建议：\u003C/b>服药时切勿用热水、碳酸饮料或乳制品送服，会影响药物溶解及吸收。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-3\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">三、作用机制简单看\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        以索拉非尼为代表的口服靶向药，能阻断肿瘤细胞多条信号通路，抑制新生血管的生成，间接延缓肿瘤增殖。类似成分如仑伐替尼，则在多靶点酪氨酸激酶层面有更强的结合能力。\u003Cbr>\n        \u003Cspan class=\"material-key-tip\">必要说明：\u003C/span>此部分只介绍药物如何“阻断靶点”，并不涉及具体治疗范围。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg-4\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">四、服药时间、用量与服用技巧⏰\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        1. \u003Cb>服用时间\u003C/b>：绝大多数口服靶向药建议在\u003Cstrong>每天固定时间\u003C/strong>服用。部分产品为\u003Cb>空腹（餐前至少1小时或餐后2小时）\u003C/b>，也有可以在进食期间用药的种类，具体以药品说明书为准。\n      \u003C/p>\n      \u003Cp>\n        2. \u003Cb>用量\u003C/b>：\u003Cspan class=\"material-tip-icon\">⚠️\u003C/span> 推荐用量需根据药品规格、体重及耐受性个体化调整，一般为 \u003Cstrong>每日一次或分次服用\u003C/strong>。必须在专业医生指导下严格执行；\u003Cb>不得自行增减剂量\u003C/b>。\n      \u003C/p>\n      \u003Cp>\n        3. \u003Cb>服药技巧\u003C/b>：\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>整片（或整粒）吞服，服药前后均需饮足量温水。\u003C/li>\n          \u003Cli>如为胶囊剂型，勿拆分胶囊内容物。\u003C/li>\n          \u003Cli>服药与进餐关系极为重要：如说明书中建议空腹服用，餐后2小时内服药可能导致吸收率不确定。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">👀\u003C/span>\n        \u003Cb>案例提示：\u003C/b>一位69岁男性患者按照医生要求每日清晨空腹用药，避免与食物同服，副作用更易控。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-5\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">五、禁忌与用药限制❌\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        1. \u003Cb>禁忌人群\u003C/b>：\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>对药品任一成分过敏者严禁使用。\u003C/li>\n          \u003Cli>严重肝肾功能障碍时须个体化评估。\u003C/li>\n          \u003Cli>孕妇和哺乳期妇女一般不推荐（详情见特殊人群用药部分）。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        2. \u003Cb>过量风险\u003C/b>：出现恶心、呕吐、腹泻等严重不适症状。\u003Cspan class=\"material-tip-icon\">📞\u003C/span>出现大量误服请立即前往医院就诊，随身携带药品包装。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg-6\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">六、药物相互作用与联合用药\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">🔄\u003C/span> 口服靶向药与许多常用药品有相互作用，常见有以下几类：\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>质子泵抑制剂、抗酸药物：部分靶向药依赖胃酸分解，联合使用会降低疗效。\u003C/li>\n          \u003Cli>抗生素、抗真菌药、抗结核药：个别药物能诱导酶加速分解或者抑制药物代谢，影响血中浓度。\u003C/li>\n          \u003Cli>同类小分子靶向新药，请严格遵医嘱避免同时使用。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-key-tip\">正确做法：\u003C/span>用药前，主动向医生报告所有正在服用的药物名单，包括：维生素、保健品、中成药等。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-key-tip\">建议：\u003C/span>若需联合用药，至少间隔1小时，并密切监控副作用及疗效。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg-7\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">七、常见不良反应及预警标志🚦\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        根据产品说明书与临床研究，口服靶向药物最常见副作用有：\n        \u003C/p>\u003Col class=\"material-list\">\n          \u003Cli>手足皮肤反应（干裂、发红）\u003C/li>\n          \u003Cli>皮疹、脱发\u003C/li>\n          \u003Cli>腹泻、口腔黏膜反应\u003C/li>\n          \u003Cli>厌食、轻度恶心\u003C/li>\n          \u003Cli>高血压和蛋白尿（部分药品）\u003C/li>\n        \u003C/ol>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">➡️\u003C/span>\u003Cb>正确做法：\u003C/b>初次出现上述症状，大部分可通过及时保湿、调整饮食、暂时减量等方式缓解。若症状持续，主动联系专业医师。\n      \u003C/p>\n      \u003Cp>\n        举例说明：临床研究显示，索拉非尼用药期间，约30%患者出现轻至中度皮肤不良反应（Llovet et al., 2008）。\n      \u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">❗\u003C/span>\u003Cb>严重反应预警：\u003C/b>出现明显头晕乏力、无法进食、高热、严重腹泻或黄疸等情况，需立即到医院处理。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-8\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">八、特殊人群的用药细节💡\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cb>1. 老年人：\u003C/b>肝肾功能减退者需调整剂量，监测更为密切。举例：一位70岁患者初用靶向药后，依据耐受情况逐步调整剂量，效果更稳定。\n      \u003C/p>\n      \u003Cp>\n        \u003Cb>2. 孕妇与哺乳期女性：\u003C/b>大多数靶向药具有生殖毒性，孕妇与哺乳期女性需严格禁用，或采用可靠避孕方法。\u003Cbr>\n        \u003Cspan class=\"material-key-tip\">小贴士：\u003C/span>用药期间及停止用药后至少6个月需避孕。\n      \u003C/p>\n      \u003Cp>\n        \u003Cb>3. 儿童：\u003C/b>目前绝大多数靶向药缺乏18岁以下人群安全性证据，慎用或禁用。\n      \u003C/p>\n      \u003Cp>\n        \u003Cb>4. 肝肾损伤患者：\u003C/b>依据个体肝、肾功能定期评估剂量，必要时调整或停用，详细方案听从专业医师。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-9\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">九、储存、有效期与过期处置🕰️\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>靶向药多要求\u003Cstrong>密闭、干燥、避光贮存\u003C/strong>，最佳温度为15℃-30℃。\u003C/li>\n          \u003Cli>若为板装药品，应保留原包装密封存放，开封后应在说明书注明时限内服用完。\u003C/li>\n          \u003Cli>药品过期或变色、破损，绝不能自行服用。未用完的药物可交至药店或医疗机构专用回收点处理。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        \u003Cspan class=\"material-key-tip\">温度波动过大\u003C/span>或高湿环境会显著影响药效，需避免浴室、厨房等地长期放药。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-10\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">十、漏服和过量服药该如何处理？🤔\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        \u003Cb>漏服处理：\u003C/b>\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>若距离下次服药时间超过8小时，可尽快补服；\u003C/li>\n          \u003Cli>如即将到达下一次服药时间，则直接略过，切勿加倍。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        \u003Cb>过量服用：\u003C/b>\n        \u003C/p>\u003Cul class=\"material-list\">\n          \u003Cli>一旦误服超量，立即停止用药，保存所有剩余药物与包装，尽快就医。\u003C/li>\n          \u003Cli>不可自行催吐或等待不适自行缓解。\u003C/li>\n        \u003C/ul>\n      \u003Cp>\u003C/p>\n      \u003Cp>\n        数据表明，部分靶向药如索拉非尼、仑伐替尼等一旦服用超剂量，可能会急性诱发严重副反应（Wilhelm et al., 2004；Kudo et al., 2018）。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg-11\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">十一、用药经验分享与提醒🏅\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cul class=\"material-list\">\n        \u003Cli>用药期间，请一定遵照个人剂量方案。切勿与亲友自行互换药品或随意调整剂量。\u003C/li>\n        \u003Cli>每两周至一月定期检测血常规、肝肾功能，便于早期发现异常。\u003C/li>\n        \u003Cli>用药过程中若遇到不适或疑问，不要拖延，随时与专业医师沟通。\u003C/li>\n        \u003Cli>家属协助患者监测每日用药和反应，能有效减少用药差错。\u003C/li>\n        \u003Cli>不要轻信网络或非官方渠道的用药建议和所谓“替代方案”。\u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"material-tip-icon\">🌟\u003C/span> 总结起来，靶向药用法严格、监测细致、个体差异大，需要家庭和医疗团队密切配合。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section material-bg-12\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">十二、重点回顾与安全用药倡议🔖\u003C/h2>\n    \u003Cdiv class=\"material-section-content\">\n      \u003Cp>\n        总结以上内容，针对肝癌IV期腺癌全身治疗常见的口服靶向药，我们要记住：\n      \u003C/p>\n      \u003Col class=\"material-list\">\n        \u003Cli>严格按照剂型要求服药，不擅自掰开或咬碎。\u003C/li>\n        \u003Cli>每日按时服用，关注与食物的关系，拒绝自行调整剂量。\u003C/li>\n        \u003Cli>出现不良反应要及时与医生沟通，重视并报告所有联合用药。\u003C/li>\n        \u003Cli>高温、潮湿环境下储存危害大，药品定期检查。\u003C/li>\n        \u003Cli>特殊人群需个体化方案，孕妇与哺乳期女性严禁自行用药。\u003C/li>\n      \u003C/ol>\n      \u003Cp>\n        您和家人的安全用药，一半靠科学指导，一半靠生活细心。只有坚持这些细节，才能让靶向药真正发挥价值。\u003Cb>如需进一步咨询，请随时联系就医团队。\u003C/b>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg-13\">\n    \u003Ch2 class=\"material-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cdiv class=\"material-section-content material-cite-list\">\n      \u003Col>\n        \u003Cli>Llovet, J. M., Ricci, S., Mazzaferro, V., et al. (2008). Sorafenib in advanced hepatocellular carcinoma. \u003Ci>N Engl J Med, 359\u003C/i>(4), 378-390. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18650514/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Wilhelm, S. M., Carter, C., Tang, L., et al. (2004). BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. \u003Ci>Cancer Research, 64\u003C/i>(19), 7099–7109. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15466206/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Kudo, M., Finn, R. S., Qin, S., et al. (2018). Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomized phase 3 non-inferiority trial. \u003Ci>Lancet, 391\u003C/i>(10126), 1163-1173. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29433850/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  max-width: 760px;\n  margin: 48px auto;\n  padding: 36px 28px 32px 28px;\n  background: #fafbfc;\n  border-radius: 18px;\n  box-shadow: 0 4px 24px rgba(38,60,128,0.09);\n  color: #2c3040;\n  line-height: 1.78;\n  font-size: 18px;\n}\n\n/* title */\n.material-title {\n  font-size: 2.4em;\n  letter-spacing: 1.5px;\n  font-weight: 800;\n  color: #1a237e;\n  margin: 0 0 26px 0;\n  text-align: center;\n  padding: 8px 0 22px 0;\n  border-bottom: 3px solid #b3c9f5;\n}\n\n/* section */\n.material-section {\n  margin: 32px 0 0 0;\n  border-radius: 11px;\n  box-shadow: 0 1px 9px rgba(132, 168, 239, 0.10);\n  overflow: hidden;\n  padding: 0;\n}\n\n/* section backgrounds – 淡彩渐变效果 */\n.material-bg-1 { background: linear-gradient(90deg, #e8f1fc 0%, #fafffd 100%); }\n.material-bg-2 { background: linear-gradient(90deg, #e0f3f0 0%, #f7fafc 100%); }\n.material-bg-3 { background: linear-gradient(90deg, #f6eaff 0%, #fbfcfa 100%); }\n.material-bg-4 { background: linear-gradient(90deg, #fff3ed 0%, #fbfaf8 100%); }\n.material-bg-5 { background: linear-gradient(90deg, #fffbe7 0%, #fcfbf8 100%); }\n.material-bg-6 { background: linear-gradient(90deg, #f0edf5 0%, #fafafa 100%); }\n.material-bg-7 { background: linear-gradient(90deg, #ecf4fb 0%, #f6fafd 100%); }\n.material-bg-8 { background: linear-gradient(90deg, #eaf8ee 0%, #f8fdf9 100%); }\n.material-bg-9 { background: linear-gradient(90deg, #f5f0e9 0%, #fefdfb 100%); }\n.material-bg-10 { background: linear-gradient(90deg, #eaf1fb 0%, #f8fbfa 100%); }\n.material-bg-11 { background: linear-gradient(90deg, #f4fcf6 0%, #f4f3ff 100%); }\n.material-bg-12 { background: linear-gradient(90deg, #fffaf3 0%, #fbf9fd 100%); }\n.material-bg-13 { background: linear-gradient(90deg, #ecf9fa 0%, #f8f7fa 100%); }\n\n/* section title */\n.material-section-title {\n  background: rgba(196,217,253,0.13);\n  color: #243575;\n  font-size: 1.35em;\n  letter-spacing: 1.1px;\n  font-weight: 700;\n  margin: 0 0 0 0;\n  padding: 14px 0 14px 36px;\n  border-left: 6px solid #aec7fa;\n  border-bottom: 1.5px solid #e1ebf8;\n}\n\n.material-section-content {\n  padding: 22px 28px 18px 36px;\n}\n\n/* 列表样式 */\n.material-list {\n  list-style: disc inside;\n  margin: 10px 0 10px 24px;\n  padding: 0 0 0 10px;\n}\n.material-list > li {\n  margin: 8px 0 0 0;\n  padding-left: 0;\n}\n.material-list > ol {\n  list-style-type:decimal;\n  margin-left: 26px;\n}\n\n/* 小标签与高亮 */\n.material-key-tip {\n  display: inline-block;\n  color: #334292;\n  font-weight: 700;\n  background: rgba(211,229,255,0.28);\n  border-radius: 6px;\n  padding: 2.5px 8px;\n  margin: 0 4px 0 0;\n  font-size: 95%;\n}\n.material-tip-icon {\n  font-size: 1.2em;\n  margin-right: 2px;\n}\n\n/* 文献格式 */\n.material-cite-list {\n  margin: 10px 0 0 10px;\n  font-size: 0.96em;\n  color: #59505e;\n}\n.material-cite-list ol {\n  padding-left: 22px;\n}\n\n/* 响应式适配 */\n@media (max-width: 900px) {\n  .material-container { max-width: 98vw;}\n  .material-section-content { padding: 12px 10px 11px 14px;}\n  .material-title { font-size: 1.5em;}\n}\n\u003C/style>\n",287,"2025-07-01 16:29:43","肝癌, IV期腺癌, 口服靶向药物, 索拉非尼, 仑伐替尼, 不良反应, 用药指导, 安全用药, 孕妇用药","了解肝癌IV期腺癌患者常用口服靶向药物的使用方法与注意事项，掌握安全用药技能和不良反应处理，确保治疗有效。","2025-07-02 00:06:00",2,[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]